Qureshi, K.A.; Imtiaz, M.; Al Nasr, I.; Koko, W.S.; Khan, T.A.; Jaremko, M.; Mahmood, S.; Fatmi, M.Q.
Antiprotozoal Activity of Thymoquinone (2-Isopropyl-5-methyl-1,4-benzoquinone) for the Treatment of Leishmania major-Induced Leishmaniasis: In Silico and In Vitro Studies. Antibiotics 2022, 11, 1206.
https://doi.org/10.3390/antibiotics11091206
AMA Style
Qureshi KA, Imtiaz M, Al Nasr I, Koko WS, Khan TA, Jaremko M, Mahmood S, Fatmi MQ.
Antiprotozoal Activity of Thymoquinone (2-Isopropyl-5-methyl-1,4-benzoquinone) for the Treatment of Leishmania major-Induced Leishmaniasis: In Silico and In Vitro Studies. Antibiotics. 2022; 11(9):1206.
https://doi.org/10.3390/antibiotics11091206
Chicago/Turabian Style
Qureshi, Kamal A., Mahrukh Imtiaz, Ibrahim Al Nasr, Waleed S. Koko, Tariq A. Khan, Mariusz Jaremko, Syed Mahmood, and M. Qaiser Fatmi.
2022. "Antiprotozoal Activity of Thymoquinone (2-Isopropyl-5-methyl-1,4-benzoquinone) for the Treatment of Leishmania major-Induced Leishmaniasis: In Silico and In Vitro Studies" Antibiotics 11, no. 9: 1206.
https://doi.org/10.3390/antibiotics11091206
APA Style
Qureshi, K. A., Imtiaz, M., Al Nasr, I., Koko, W. S., Khan, T. A., Jaremko, M., Mahmood, S., & Fatmi, M. Q.
(2022). Antiprotozoal Activity of Thymoquinone (2-Isopropyl-5-methyl-1,4-benzoquinone) for the Treatment of Leishmania major-Induced Leishmaniasis: In Silico and In Vitro Studies. Antibiotics, 11(9), 1206.
https://doi.org/10.3390/antibiotics11091206
